Brawn Biotech Complete Financial Statements
In FY2023, Brawn Biotech (BRAWN) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.47. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review BRAWN PE ratio trends to evaluate earnings-based valuation against sector peers.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
BRAWN Revenue, Net Profit & EBITDA — Year-on-Year Growth
BRAWN YoY (Jun 2022 vs Mar 2023). For live price, earnings ratios and company overview, see Brawn Biotech screener.
BRAWN Income Statement — Revenue, EBITDA & Net Profit
Brawn Biotech revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.47 (2023). Explore BRAWN Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
| Particulars | Mar 2023 | Jun 2023 | Jun 2022 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 |
| EBITDA | 0 | 0 | 0 |
| Operating Profit Margin % | 25.00% | -33.00% | 25.00% |
| Depreciation | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.47 | -0.08 | 0.05 |
BRAWN Balance Sheet — Assets, Liabilities & Shareholders' Equity
BRAWN total assets ₹21 Cr, total equity ₹3 Cr, total liabilities ₹ Cr (2025).
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 21 | 15 | 15 | 14 | 14 | 20 | 23 | 23 | 17 | 14 | 14 |
| Current Assets | 18 | 13 | 13 | 12 | 13 | 19 | 22 | 22 | 17 | 11 | 11 |
| Fixed Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 14 | 14 | 13 | 14 | 20 | 22 | 22 | 17 | 14 | 14 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 8 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 3 | 5 | 6 | 7 | 9 | 9 | 9 | 8 | 7 | 6 | 5 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 0 | 2 | 3 | 4 | 6 | 6 | 6 | 5 | 4 | 3 | 2 |
BRAWN Cash Flow Statement — Operating, Investing & Financing
Brawn Biotech operating cash flow ₹0 Cr, investing ₹0 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 2 | 0 | 0 |